Guggenheim raises Legence price target to $115
Guggenheim analyst Joseph Osha maintains a Buy rating on Legence and raises the price target to $115 from $106, reflecting a positive outlook on the company's stock.
*this image is generated using AI for illustrative purposes only.
Guggenheim analyst Joseph Osha has maintained a Buy rating on Legence and raised the price target to $115 from $106. The revised target indicates a positive outlook for the company's stock performance.
Rating and Price Target Details
The analyst's decision to upgrade the price target comes as Legence continues to show strong market potential. The new target of $115 represents an increase from the previous $106, suggesting further upside for investors.
| Metric | Value |
|---|---|
| Rating | Buy |
| Previous Price Target | $106 |
| New Price Target | $115 |
Legence, listed on NASDAQ under the ticker LGN, is expected to benefit from the revised target as it signals confidence from Guggenheim in its future growth.
What specific market trends or catalysts are driving Guggenheim's increased confidence in Legence's growth?
How does the new $115 price target compare to the average analyst consensus for Legence?
What are the potential risks that could prevent Legence from reaching the revised price target?
15
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
